ANAPTYSBIO CEO Hamza Suria's 2018 pay jumps 28% to $5.1M
ANAPTYSBIO reports 2018 executive compensation
By ExecPay News
Published: April 26, 2019
ANAPTYSBIO reported fiscal year 2018 executive compensation information on April 26, 2019.
In 2018, four ANAPTYSBIO executives received on average a compensation package of $3M, a 27% increase compared to previous year.
Average pay of disclosed executives at ANAPTYSBIO
Hamza Suria, Chief Executive Officer, received $5.1M in total, which increased by 28% compared to 2017. 84% of Suria's compensation, or $4.3M, was in option awards. Suria also received $271K in non-equity incentive plan, $547K in salary, as well as $540 in other compensation.
Marco Londei, Chief Medical Officer, received a compensation package of $2.5M, which increased by 17% compared to previous year. 76% of the compensation package, or $1.9M, was in option awards.
Eric Loumeau, General Counsel, earned $2.2M in 2018.
Dominic Piscitelli, Chief Financial Officer, received $2.1M in 2018, which decreases by 26% compared to 2017.
Related executives
You may also like
Source: SEC filing on April 26, 2019.